Home › Research › Digital health tools
Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models
Kavitha C, Mani V, Srividhya SR, Khalaf OI, Tavera Romero CA.. Frontiers in public health, 2022-03-03
Topic: Amyloid, tau and blood-test diagnosis
Alzheimer's disease (AD) is the leading cause of dementia in older adults. There is currently a lot of interest in applying machine learning to find out metabolic diseases like Alzheimer's and Diabetes that affect a large population of people around the world. Their incidence rates are increasing at an alarming rate every year. In Alzheimer's disease, the brain is affected by neurodegenerative changes. As our aging population increases, more and more individuals, their families, and healthcare will experience diseases that affect memory and functioning. These effects will be profound on the social, financial, and economic fronts. In its early stages, Alzheimer's disease is hard to predict. A treatment given at an early stage of AD is more effective, and it causes fewer minor damage than a treatment done at a later stage. Several techniques such as Decision Tree, Random Forest, Support Vector Machine, Gradient Boosting, and Voting classifiers have been employed to identify the best parameters for Alzheimer's disease prediction. Predictions of Alzheimer's disease are based on Open Access Series of Imaging Studies (OASIS) data, and performance is measured with parameters like Precision, Recall, Accuracy, and F1-score for ML models. The proposed classification scheme can be used by clinicians to make diagnoses of these diseases. It is highly beneficial to lower annual mortality rates of Alzheimer's disease in early diagnosis with these ML algorithms. The proposed work shows better results with the best validation average accuracy of 83% on the test data of AD. This test accuracy score is significantly higher in comparison with existing works.
Key findings
- The proposed work shows better results with the best validation average accuracy of 83% on the test data of AD.
- This test accuracy score is significantly higher in comparison with existing works.
Why it matters
This study used several machine learning classifiers on imaging data to predict early-stage Alzheimer's disease, with the best validation average accuracy of 83%. It is a prediction study and does not test any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Evidence strengthLow
How this study scored 53/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in public health) |
| Journal's citation record | 2 / 4 | Frontiers in Public Health: journal h-index 174 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 371 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 61.8 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 6 / 6 | Cited 45.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 4 / 4 | Cited 287 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Carlos Andrés Tavera Romero: h-index 24 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Sathyabama Institute of Science and Technology: institution h-index 187 (OpenAlex) |
| Multi-centre collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35309200) |
| Free to read | 2 / 2 | Free to read |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fpubh.2022.853294
- PubMed: 35309200
- Original source →
- Free full text: Frontiers in Public Health →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Kavitha, C., Mani, V., Srividhya, SR., Khalaf, O. I., & Tavera Romero, C. A. (2022). Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models. Frontiers in public health. https://doi.org/10.3389/fpubh.2022.853294
Vancouver
Kavitha C, Mani V, Srividhya SR, Khalaf OI, Tavera Romero CA. Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models. Frontiers in public health. 2022. doi:10.3389/fpubh.2022.853294. PMID: 35309200.
BibTeX
@article{kavitha2022-35309200,
author = {Kavitha, C. and Mani, V. and Srividhya, SR. and Khalaf, O. I. and Tavera Romero, C. A.},
title = {{Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models}},
journal = {Frontiers in public health},
year = {2022},
doi = {10.3389/fpubh.2022.853294},
pmid = {35309200},
url = {https://doi.org/10.3389/fpubh.2022.853294}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.